Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Drug Discovery TodayOpen Access

On-body drug delivery systems: State-of-the-art technologies, clinical application, and future perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

RDRossella DoratiDCDonato CoscoLBLuigi Battaglia

Discussion

Loading...

Member takes

Overview

This analysis uncovers the impact of on-body drug delivery systems on patient compliance and economic sustainability.

Key Points

  • On-body drug delivery systems improve the delivery of doses exceeding 2 ml, enhancing therapeutic options for patients.
  • Recent innovations include devices classified as either medical devices or medicinal products, addressing pain and injectability issues.
  • Assessments consider biopharmaceutical requirements and economic sustainability, highlighting patient-specific treatment needs.
  • Market concerns about the adoption of these systems suggest a need for addressing patient compliance for better outcomes.

Cite This Study

Dorati et al. (2025) studied this question.

synapsesocial.com/papers/68c1aac654b1d3bfb60e31f7https://doi.org/10.1016/j.drudis.2025.104441
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1From Oral to Subcutaneous Furosemide: The Road to Novel Opportunities to Manage Congestion2022 · 12 citations
  2. 2Clinical Insights Into a New, Disposable Insulin Delivery Device2015 · 12 citations
  3. 3Barriers to cancer treatment and care for people experiencing structural vulnerability: a secondary analysis of ethnographic data2023 · 32 citations
  4. 4Pegfilgrastim: using pegylation technology to improve neutropenia support in cancer patients2003 · 84 citations
  5. 5Psychological and Clinical Challenges in the Management of Type 1 Diabetes during Adolescence: A Narrative Review2024 · 45 citations